Solving Challenges with Third-Party Logistics

By Peter Belden |

The rise of fully integrated third-party logistics (3PL) companies has transformed what once was a provider-based service into a strategic, consultative partnership — one that can help pharmaceutical companies ensure greater patient access and commercialization success. Pete Belden, President of ICS, speaks to PharmaVOICE about what it means to go beyond distribution and what it could mean for the future of pharmaceutical manufacturing.

Click the button below to download the podcast. Click here to read the full transcript.


About the Author

Peter Belden is responsible for the strategic and operational oversight of ICS, a business unit of AmerisourceBergen. Mr. Belden joined ICS in August 2014 and, prior to this role, spent 11 years with the AmerisourceBergen Packaging Group where he held roles of increasing responsibility across Sales, Marketing, and General Management leading the US and UK pharmaceutical contract packaging units.
View Bio